Consequently, whether VM exerts a favorable influence on renal cancer prognosis through alternative pathways or if PRDX2 affects ccRCC prognosis via mechanisms distinct from VM remains unclear. Here, PRDX2 is linked to nonpapillary renal cell carcinoma.